Cholesterol Efflux and Atheroprotection
2012 · Circulation · 933 citations
https://doi.org/10.1161/circulationaha.111.066589
R
Robert S. Rosenson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
622
Papers
27.0K
Citations
79
h-index
294
i10-index
Robert S. Rosenson is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Diabetes, Cardiovascular Risks, and Lipoproteins & Cancer, Lipids, and Metabolism. The author has an h-index of 79, co-authored 529 publications.
ORCID: 0000-0002-5599-0633Papers by this author
worksSmall Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
2022 · New England Journal of Medicine · 451 citations
https://doi.org/10.1056/nejmoa2211023
Deep learning for cardiovascular medicine: a practical primer
2019 · European Heart Journal · 381 citations
https://doi.org/10.1093/eurheartj/ehz056
Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction
2017 · Journal of the American College of Cardiology · 315 citations
https://doi.org/10.1016/j.jacc.2016.12.036
The Role of Nutraceuticals in Statin Intolerant Patients
2018 · Journal of the American College of Cardiology · 267 citations
https://doi.org/10.1016/j.jacc.2018.04.040
Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts
2022 · The Lancet · 145 citations
https://doi.org/10.1016/s0140-6736(22)02079-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat